Meet Asmaa Salah Abdel Khalek, a Clinical Trial Evaluator and Auditor at the EDA, the Egyptian Drug Authority.
The IFAPP Academy is proud to provide continuing professional development to Medical Affairs Professionals worldwide. This month, we would like to introduce you to, Asmaa Salah Abdel Khalek, a current student of the IFAPP Academy/King’s College, Medical Affairs in Medicines Development, Certification Program.
What is your name and job title?
I’m Asmaa Salah Abdel Khalek, Clinical Trial evaluator and auditor at the EDA, the Egyptian Drug Authority.
What do you feel is your greatest achievement?
My greatest achievement could be simplified in my dream to improve the clinical trial regulation in my country, to cope with the international guidelines.
Currently, I’m working in the national NRA and due to my continuous search and education in the clinical research field, I can see a lot of obvious gaps in the regulations of the clinical trials in my country. I truly hope to be one of the team that will standardize and unify the clinical trial regulations which will have a great impact on the provided pharmaceutical services across all the different healthcare sectors. You start to improve the moment you figure out the weak points and work on them.
What is your favorite hobby and/or activity outside of your work?
My favorite hobby is walking in an open area, listening to my favorite music.
What do you enjoy most about being a Medical Affairs Professional?
First, it was a great honor for me to hear about the medical affairs professional degree provided by IFAPP. I’m totally interested in this specialty which is now the direction of all the huge pharmaceutical companies. Working in a patient-centered approach, integrating the medical affairs specialists as key members along the entire product lifecycle. Through a mutual collaboration with all the company staff, starting from studying the market to detecting the medical needs, aiming to meet these needs, then helping the academic scientists to deliver their basic research and input, to shift from bench to lab, and then the huge massive clinical trial initiation, and monitoring, regulatory approval and marketing authorization, marketing plan starting from studying the market, targeting the main stakeholder, positioning etc.…. followed by the post-marketing and outcome research studies that may help to support the product value. Medical affairs is a broad concept, it could be an MSL, CRA, marketing team, regulatory affairs and so much more.
This is a new direction with a great impact, improving the performance. And for me, I’m completely interested in the clinical research sections and regulation pre and post-marketing authorization.
What has been the most beneficial aspect of the IFAPP Academy Program?
The most beneficial aspect of the IFAPP Academy Program is its professional organization which truly helped me to make a complete picture of the medical affairs profession. Also, the lecturers, listening to these lectures from professional professors who already have a great experience and are completely updated in that field was very helpful. Lastly, the rich content and the flexibility of the program.
How has your view of the medical affairs profession altered and/or improved?
The medical affairs profession altered to be patient-centered and improved to make a great progress across all the product lifecycle, integrating with all other sectors in the company.
Any additional comments that you would like to make about the IFAPP Academy/King’s College, Medical Affairs in Medicines Development, Certification Program?
I would like to say thank you to all the IFAPP team and the program director for their patience and the great support they presented to us in this great program.
Thank you, Asmaa! The Academy looks forward to seeing your many great achievements and contributions to the Medical Affairs arena.
Want to learn more about the IFAPP Academy?
The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (IFAPP) Academy provides online Continuing Professional Development for Medical Affairs Professionals.
King’s College London: “From Molecules to Medicine”
King’s College London, IFAPP Academy’s academic partner, has a strong tradition in pharmaceutical science.
King’s College London has a strong tradition in pharmaceutical science, world-class pharmacology, clinical pharmacology, and therapeutics. This has led to the creation of a number of spin-out companies, including MedPharm and Proximagen Neuroscience plc.
The School of Cancer and Pharmaceutical Science was created to bring together the relevant research groupings across King’s College London.
Molecules to Medicine’s strategy is designed to capture and highlight the broad sweep of research at King’s ranging from pharmacological and chemical studies that can identify novel drug targets and new chemical entities, through formulation and drug development, to clinical trials and the use of medicines by patients. The all-embracing strategy is for researchers to work together towards the discovery of novel medicines and new formulations that can be evaluated in patients in the clinic.
To achieve this goal, and to provide focus, research activities are organized into three related themes: Drug Discovery, Medicines Development, and Medicines Use. Each of these themes includes clusters of research activity, some of which have evolved during the past decade (e.g. drug delivery, chemical biology, pharmaceutical biophysics, pharmacology), and some of which have joined King’s more recently such as enhanced activity in anticancer and anti-infective drug discovery, nanomedicines, substance abuse, health psychology, and clinical pharmacy. Researchers within and across the three themes interact both informally and via joint initiatives to promote cross-disciplinary research. For example, the drug delivery activities of Forbes, Jones, and Daily, working closely with colleagues in pharmacology (Page/Spina) have led to consortium funding and several Ph.D. studentships from the MRC to investigate the safety of nanoparticles in the airways.
The IFAPP Academy in partnership with King’s College London offers Academic and Professional Certification for students successfully completing the Medical Affairs in Medicines Development course. To learn about the benefits of Certification from the IFAPP Academy, visit us at https://ifappacademy.org/index.php/ifapp-academy-benefits/
Professor Peter Stonier, Co-director of the Medical Affairs Certification program says:
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).